With Tirzepatide, our patients gain access to advanced medical treatment options designed to achieve meaningful, sustained weight loss and lasting improvements in overall metabolic wellness
NICE guidelines suggest reassessing after 6 months, with continued prescription only if youve lost at least 5% of your starting weight
Patients who lose the most weight on GLP-1s tend to make protein-forward food choices, stay hydrated (GLP-1s slow gastric emptying and dehydrate patients faster than they realize), prioritize sleep (sleep deprivation drives weight regain), and add some form of strength training
In contrast, Ozempic uses lower doses (up to 2.0 mg) aimed primarily at blood sugar control, though it also causes weight loss
GLP-1 and GLP-1/GIP medications may improve blood sugar, insulin resistance, A1C, cholesterol, blood pressure, fatty liver disease, sleep apnea, inflammation, and cardiovascular risk in appropriate patients